Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation

Neuropeptides

Volumn 41, Issue 6, 2007, Pages 399-410

  Green, Megan K ^a   Barbieri, Emily V ^a   Brown, Brandon D ^a   Chen, Kir Wei ^a   Devine, Darragh P ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Amygdala; Anxiety; BNST; HPA axis; Limbic system; N OFQ; Nociceptin; Open field; Orphanin FQ; Stress

Indexed keywords

CORTICOSTERONE; NOCICEPTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN CORTEX; BRAIN STEM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LATERAL BRAIN VENTRICLE; MALE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; STRESS; STRIA TERMINALIS;

AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIMBIC SYSTEM; MALE; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, LONG-EVANS;

RATTUS; RODENTIA;

EID: 36049049433     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2007.09.002     Document Type: Article

References (36)

1. Adamec R.E., Blundell J., and Collins A. Neural plasticity and stress induced changes in defense in the rat. Neurosci. Biobehav. Rev. 25 (2001) 721-744
2. Coleman-Mesches K., and McGaugh J.L. Differential involvement of the right and left amygdalae in expression of memory for aversively motivated training. Brain Res. 670 (1995) 75-81
3. Coleman-Mesches K., and McGaugh J.L. Muscimol injected into the right or left amygdaloid complex differentially affects retention performance following aversively motivated training. Brain Res. 676 (1995) 183-188
4. Danielson P.B., and Dores R.M. Molecular evolution of the opioid/orphanin gene family. Gen. Comp. Endocrinol. 113 (1999) 169-186
5. Dautzenberg F.M., Wichmann J., Higelin J., Py-Lang G., Kratzeisen C., Malherbe P., Kilpatrick G.J., and Jenck F. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo. J. Pharmacol. Exp. Ther. 298 (2001) 812-819
6. Devine D.P., Taylor L., Reinscheid R.K., Monsma Jr. F.J., Civelli O., and Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem. Res. 21 (1996) 1387-1396
7. Devine D.P., Watson S.J., and Akil H. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis. Neuroscience 102 (2001) 541-553
8. Fernandez F., Misilmeri M.A., Felger J.C., and Devine D.P. Nociceptin/orphanin FQ increases anxiety-related behaviour and circulating levels of corticosterone during neophobic tests of anxiety. Neuropsychopharmacology 29 (2004) 59-71
9. Florin S., Suaudeau C., Meunier J.C., and Costentin J. Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur. J. Pharmacol. 317 (1996) 9-13
10. Gavioli E.C., Rae G.A., Caló G., Guerrini R., and De Lima T.C. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test. Brit. J. Pharmacol. 136 (2002) 764-772
11. Gavioli E.C., Rizzi A., Marzola G., Zucchini S., Regoli D., and Calo' G. Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice. Peptides 28 (2007) 1229-1239
12. Griebel G., Perrault G., and Sanger D.J. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res. 836 (1999) 221-224
13. Ixart G., Szafarczyk A., Belugou J.L., and Assenmacher I. Temporal relationships between the diurnal rhythm of hypothalamic corticotrophin releasing factor, pituitary corticotrophin and plasma corticosterone in the rat. J. Endocrinol. 72 (1977) 113-120
14. Jenck F., Moreau J.-L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma Jr. F.J., Nothacker H.-P., and Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. USA 94 (1997) 14854-14858
15. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R., Lundstrom K., Cesura A.M., Poli S.M., Roever S., Kolczewski S., Adam G., and Kilpatrick G. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat. Proc. Natl. Acad. Sci. USA 97 (2000) 4938-4943
16. Kamei J., Matsunawa Y., Miyata S., Tanaka S., and Saitoh A. Effects of nociceptin on the exploratory behavior of mice in the hole-board test. Eur. J. Pharmacol. 489 (2004) 77-87
17. Kwak S.P., Morano M.I., Young E.A., Watson S.J., and Akil H. Diurnal CRH mRNA rhythm in the hypothalamus: decreased expression in the evening is not dependent on endogenous glucocorticoids. Neuroendocrinology 57 (1993) 96-105
18. LaBar K.S., and LeDoux J.E. Partial disruption of fear conditioning in rats with unilateral amygdala damage: correspondence with unilateral temporal lobectomy in humans. Behav. Neurosci. 110 (1996) 991-997
19. Marc V., and Morselli P.L. Effect of diazepam on plasma corticosterone levels in the rat. J. Pharm. Pharmacol. 21 (1969) 784-786
20. Meis S. Nociceptin/orphanin FQ: actions within the brain. Neuroscientist 9 (2003) 158-168
21. 1 receptor. Nature 377 (1995) 532-535
22. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 (2003) 83-244
23. Moghaddam B., and Bunney B.S. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J. Neurochem. 53 (1989) 652-654
24. 125I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412 (1999) 563-605
25. Neal Jr. C.R., Mansour A., Reinscheid R.K., Nothacker H.-P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 (1999) 503-547
26. Nicholson J.R., Akil H., and Watson S.J. Orphanin FQ-induced hyperphagia is mediated by corticosterone and central glucocorticoid receptors. Neuroscience 115 (2002) 637-643
27. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego, CA
28. Pellow S., and File S.E. The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response. Physiol. Behav. 35 (1985) 587-590
29. Reinscheid R.K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr. F.J., and Civelli O. Orphanin FQ: A neuropeptide that activates an opioidlike G-protein-coupled receptor. Science 270 (1995) 792-794
30. Rogan M.T., Staubli U.V., and LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390 (1997) 604-607
31. Scicli A.P., Petrovich G.D., Swanson L.W., and Thompson R.F. Contextual fear conditioning is associated with lateralized expression of the immediate early gene c-fos in the central and basolateral amygdalar nuclei. Behav. Neurosci. 118 (2004) 5-14
32. Singewald N., Salchner P., and Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol. Psychiat. 53 (2003) 275-283
33. Singewald N., and Sharp T. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98 (2000) 759-770
34. Varty G.B., Hyde L.A., Hodgson R.A., Lu S.X., McCool M.F., Kazdoba T.M., Del Vecchio R.A., Guthrie D.H., Pond A.J., Grzelak M.E., Xu X., Korfmacher W.A., Tulshian D., Parker E.M., and Higgins G.A. Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species. Psychopharmacology (Berl) 182 (2005) 132-143
35. Vitale G., Arletti R., Ruggieri V., Cifani C., and Massi M. Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides 27 (2006) 2193-2200
36. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur. J. Pharmacol. 463 (2003) 199-216